Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Diseases, Disorders & Medical Epilepsy Study Consortium Inc.

Epilepsy Study Consortium Inc.

Fiscal year ending 2023. Filed on August 28, 2024.

12030 Sunrise Valley Drive 450
Reston, Virginia 20191

Epilepsy Study Consortium Inc. (EIN: 20-4950952) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2023 IRS Form 990 filing, Epilepsy Study Consortium Inc., a 501(c)(3) charitable organization, reported compensation for 7 out of 7 total employees. Among the employees shown here, the average compensation is $148,699. The highest compensated employee at Epilepsy Study Consortium Inc. is Bree Diventura with fiscal year 2023 compensation of $200,319.

Revenue, expenses, and employee compensation

Revenue

$3,371,798

Expenses

$1,701,465

Employee compensation

$783,326
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Bree Diventura
Co-Executive Director
$200,319
$194,484 No related comp$5,835
Meryl Lozano
Co-Executive Director
$141,167
$141,167 No related compNo other comp
Tracy L de Vito
Employee
$104,612
$104,612 No related compNo other comp
James Lintott, Esq
Treasurer
$0
Daniel Friedman, M.D.
Vice President
$0
Jacqueline French, M.D.
President
$0
Dennis Dlugos, M.D.
Vice President
$0

Benchmark Employee Compensation

Non-Employee Board Members

Michael Gelfand, M.D.
Director
$27,413
$27,413 No related compNo other comp
Hina Dave, M.D.
Director
$1,725
$1,725 No related compNo other comp
Pavel Klein, M.D.
Director
No compensation reported
Sudha Kessler, M.D.
Director
No compensation reported
Michael Sperling, M.D.
Director
No compensation reported
Marc Dichter, M.D., Ph.D.
Director
No compensation reported
Gregory Krauss, M.D.
Director
No compensation reported
John Pollard, M.D.
Director
No compensation reported
Claude Steriade, M.D.
Director
No compensation reported

Mission Statement

ACCELERATING THE DEVELOPMENT OF NEW THERAPIES IN EPILEPSY TO IMPROVE PATIENT CARE THROUGH RESEARCH.

Revisions to this organization profile

June 30, 2025:
2024 Epilepsy Study Consortium Inc. 990 filed
August 28, 2024:
2023 Epilepsy Study Consortium Inc. 990 filed
November 15, 2023:
2022 Epilepsy Study Consortium Inc. 990 filed

Get an email when new compensation information is released for Epilepsy Study Consortium Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →